Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: A review

Fonseca, Rafaël; Yamakawa, Mitsunori; Nakamura, Shigeo; Heerde, P. Van; Miettinen, Markku; Shek, Tony W. H.; Jensen, O. Myhre; Rousselet, Marie‐Christine; Tefferi, Ayalew

doi:10.1002/(sici)1096-8652(199810)59:2<161::aid-ajh10>3.0.co;2-c

Cited by 178 publications

(113 citation statements)

References 24 publications

Supporting

Mentioning

100

Contrasting

Unclassified

Order By: Relevance

“…The roles of chemotherapy and radiotherapy have not been clearly defined. Several chemotherapeutic regimens have been tried including CHOP, ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine), DHAP (dexamethasone, cisplatin, high-dose cytarabine), EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin), ICE (ifosfamide, carboplatin, etoposide), and cisplatin/epirubicin with limited response (1, 3, 6). For the greater part, the agents used are combination chemotherapies designed for the treatment of lymphoma.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Extranodal Interdigitating Dendritic Cell Sarcoma Presenting in the Pleura: A Case Report

et al. 2011

View full text Add to dashboard Cite

Interdigitating dendritic cell sarcoma (IDCS) is an extremely rare neoplasm arising from the antigen-presenting cells of the immune system. This disease usually involves the lymph nodes, and rarely, extranodal sites may be affected. The authors report a case of extranodal IDCS presenting in the pleura. A 32-yr-old man presented with progressive chest pain. Imaging studies showed diffuse pleural thickening with pleural effusion. Morphological and immunohistochemical analysis of an incisional biopsy of the pleura were consistent with a diagnosis of IDCS; tumor cells were positive for S100 and CD45, but negative for CD1a, CD21, CD35, B cell and T cell markers. The patient was administered chemotherapy, but died of progressive disease. Although its incidence is extremely rare, this case suggests that extranodal IDCS should be considered in the differential diagnosis of undifferentiated neoplasms and that immunohistochemical staining be performed using appropriate markers.

show abstract

Section: Discussionmentioning

confidence: 99%

“…These cells are localized to areas of B cells in the germinal centers of lymphoid follicles. Interdigitating dendritic cells participate in the immune system by stimulating T lymphocytes and are found in the T cell areas of peripheral lymphoid tissues (1-3). …”

Section: Introductionmentioning

confidence: 99%

Extranodal Interdigitating Dendritic Cell Sarcoma Presenting in the Pleura: A Case Report

et al. 2011

View full text Add to dashboard Cite

show abstract

“…Since then, approximately 200 cases have been reported. FDC tumours can arise in lymph nodes or extranodal sites and express FDC markers such as CD21/CD35, CD23 and CNA.42 2. FDC tumours mainly affect middle-aged patients with no gender predilection.…”

Section: Discussionmentioning

confidence: 99%

Inflammatory pseudotumour-like follicular dendritic cell tumour of the spleen

Nishiyama

Baba

Watahiki³

et al. 2015

BMJ Case Reports

View full text Add to dashboard Cite

We describe an unusual case of a 73-year-old woman presenting with a solitary splenic mass 8 cm in diameter and an elevation of serum soluble interleukin-2 receptor level. The preoperative diagnosis was primary malignant lymphoma of the spleen. Splenectomy was conducted. Histological analysis confirmed an inflammatory pseudotumour-like follicular dendritic cell tumour that showed different clinicopathological features from those of the classic follicular dendritic cell tumour. Only 33 cases of inflammatory pseudotumour-like follicular dendritic cell tumour have so far been reported. We discuss the incidence, presentation and management of this rare disease.

show abstract

“…Several types of dendritic cells are known including follicular, interdigitating, and Langerhans' cells. 1 Each cell type provides structural and functional support of the microenvironment within lymphoid tissue. Follicular dendritic cells (FDC) belong to the accessory immune system and typically reside in lymphoid follicles.…”

Section: Discussionmentioning

confidence: 99%

Primary nasopharyngeal interdigitating dendritic cell tumor presentation and response to radiation therapy

et al. 2010

View full text Add to dashboard Cite

We report the case of a primary nasopharyngeal interdigitating dendritic cell tumor (IDDCT). A 25-year old male presented with bilateral decreased hearing, double vision, and ataxia. Flexible nasopharyngoscopy reviewed a large mass obstructing and filling the entire nasopharynx. MRI and PET-CT confirmed the presence of the primary tumor and demonstrated bilateral cervical lymphadenopathy. Biopsy of the nasopharynx revealed a hematolymphoid neoplasm with dendritic cell differentiation, most consistent with an IDDCT. The lesion was unresectable. The patient was treated with definitive radiotherapy to 66 Gy to the primary tumor and 50 Gy to the bilateral cervical lymphatics using an IMRT technique. A complete response was achieved and the patient remains disease free at the primary site 23 months after completion of radiotherapy.

show abstract

Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: A review

Cited by 178 publications

References 24 publications

Extranodal Interdigitating Dendritic Cell Sarcoma Presenting in the Pleura: A Case Report

Extranodal Interdigitating Dendritic Cell Sarcoma Presenting in the Pleura: A Case Report

Inflammatory pseudotumour-like follicular dendritic cell tumour of the spleen

Primary nasopharyngeal interdigitating dendritic cell tumor presentation and response to radiation therapy

Contact Info

Product

Resources

About